<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02258035</url>
  </required_header>
  <id_info>
    <org_study_id>s57027</org_study_id>
    <nct_id>NCT02258035</nct_id>
  </id_info>
  <brief_title>Isolation of Vitamin D Binding Protein Isoforms From Human Volunteers</brief_title>
  <official_title>Isolation of Genotype-specific Isoforms of Human Vitamin D-binding Protein (DBP/Gc)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to isolate genotype-specific DBP/Gc from homozygous human
      volunteers and use these purified proteins to cross-validate existing or novel assays for
      this serum protein and to evaluate the binding characteristics of these variants of DBP/Gc
      for different vitamin D metabolites.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Vitamin D binding protein binding characteristics (affinity constant)</measure>
    <time_frame>single blood draw at time of consultation, an expected average 4 years after curative treatment for breast cancer</time_frame>
    <description>In vitro characterization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation coefficient (r) of different DBP assays</measure>
    <time_frame>single blood draw at time of consultation, an expected average 4 years after curative treatment for breast cancer</time_frame>
    <description>In vitro characterization</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>DBP/Gc1f-1f genotype</arm_group_label>
    <description>Human volunteers homozygous for the 1f-1f (fast) genotype of DBP.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DBP/Gc1s-1s genotype</arm_group_label>
    <description>Human volunteers homozygous for the 1s-1s (slow) genotype of DBP.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DBP/Gc 2-2 genotype</arm_group_label>
    <description>Human volunteers homozygous for the 2-2 genotype of DBP.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood draw</intervention_name>
    <description>Sampling of 100-150 ml of blood</description>
    <arm_group_label>DBP/Gc1f-1f genotype</arm_group_label>
    <arm_group_label>DBP/Gc1s-1s genotype</arm_group_label>
    <arm_group_label>DBP/Gc 2-2 genotype</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum will be derived from 100-150 ml of blood and used for protein purification
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with known genotype of DBP/Gc, as identified in the clinical database of the
        Multidisciplinary Breast Centre, University Hospitals Leuven, and free of breast cancer
        recurrence at the time of blood sampling.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Generally healthy adults (≥ 18 years), non pregnant, with known DBP/Gc genotype

        Exclusion Criteria:

          -  Inability to provide written informed consent

          -  No children or pregnant women

          -  Persons with known abnormal serum proteins
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dirk Vanderschueren, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UZ Leuven</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roger Bouillon, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>UZ Leuven</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hans Wildiers, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>UZ Leuven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Hatse S, Lambrechts D, Verstuyf A, Smeets A, Brouwers B, Vandorpe T, Brouckaert O, Peuteman G, Laenen A, Verlinden L, Kriebitzsch C, Dieudonné AS, Paridaens R, Neven P, Christiaens MR, Bouillon R, Wildiers H. Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency. Carcinogenesis. 2012 Jul;33(7):1319-26. doi: 10.1093/carcin/bgs187. Epub 2012 May 23.</citation>
    <PMID>22623648</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2014</study_first_submitted>
  <study_first_submitted_qc>October 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2014</study_first_posted>
  <last_update_submitted>May 22, 2018</last_update_submitted>
  <last_update_submitted_qc>May 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vitamin D binding protein (DBP)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

